SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

China-Biotics, Inc – ‘10-K’ for 3/31/11 – ‘EX-101.SCH’

On:  Tuesday, 5/21/13, at 5:29pm ET   ·   For:  3/31/11   ·   Accession #:  1144204-13-30858   ·   File #:  1-34123

Previous ‘10-K’:  ‘10-K’ on 9/14/12 for 3/31/12   ·   Next & Latest:  ‘10-K’ on 7/12/13 for 3/31/13

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/21/13  China-Biotics, Inc                10-K        3/31/11   43:4.4M                                   Toppan Merrill/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    918K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     18K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     18K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     14K 
26: R1          Document and Entity Information                     HTML     43K 
19: R2          Consolidated Balance Sheets                         HTML    131K 
24: R3          Consolidated Balance Sheets [Parenthetical]         HTML     43K 
28: R4          Consolidated Statements of Income and Other         HTML    105K 
                Comprehensive Income                                             
39: R5          Consolidated Statements of Changes in               HTML     59K 
                Stockholders' Equity                                             
20: R6          Consolidated Statements of Changes in               HTML     16K 
                Stockholders' Equity [Parenthetical]                             
23: R7          Consolidated Statements of Cash Flow                HTML    146K 
18: R8          Organization and Description of Business            HTML     22K 
13: R9          Summary of Principal Accounting Policies            HTML     79K 
40: R10         Earnings Per Share                                  HTML     32K 
30: R11         Risks, Uncertainties, and Concentrations            HTML     24K 
29: R12         Inventories                                         HTML     21K 
34: R13         Land Use Rights                                     HTML     25K 
35: R14         Property, Plant and Equipment                       HTML     25K 
33: R15         Amount Due From/To Director                         HTML     18K 
36: R16         Convertible Notes Payable                           HTML     26K 
25: R17         Derivative Liabilities                              HTML     21K 
27: R18         Income Taxes Payable                                HTML     59K 
32: R19         Treasury Stock                                      HTML     17K 
43: R20         Capital and Statutory Reserves                      HTML     17K 
37: R21         Option Incentive Plan                               HTML     31K 
21: R22         Product Return Concessions                          HTML     16K 
31: R23         Retirement Costs                                    HTML     27K 
22: R24         Commitments and Contingencies                       HTML     36K 
12: R25         Business Segments                                   HTML     53K 
38: R26         Selected Quarterly Financial Data                   HTML     29K 
41: R27         Public Offering                                     HTML     17K 
17: R28         Subsequent Events                                   HTML     24K 
15: R29         Condensed Parent Company Financial Statements       HTML    213K 
42: XML         IDEA XML File -- Filing Summary                      XML     57K 
14: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    549K 
 6: EX-101.INS  XBRL Instance -- chbt-20110331                       XML    729K 
 8: EX-101.CAL  XBRL Calculations -- chbt-20110331_cal               XML    101K 
 9: EX-101.DEF  XBRL Definitions -- chbt-20110331_def                XML    208K 
10: EX-101.LAB  XBRL Labels -- chbt-20110331_lab                     XML    470K 
11: EX-101.PRE  XBRL Presentations -- chbt-20110331_pre              XML    280K 
 7: EX-101.SCH  XBRL Schema -- chbt-20110331                         XSD     69K 
16: ZIP         XBRL Zipped Folder -- 0001144204-13-030858-xbrl      Zip     74K

‘EX-101.SCH’   —   XBRL Schema — chbt-20110331

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Modified with Ez-Editor Version 1.0.2.9 by DataTracks on Wednesday, May 22, 2013 02:04:55 AM -->
<schema targetNamespace="http://www.chn-biotics.com/20110331" elementFormDefault="qualified" xmlns:chbt="http://www.chn-biotics.com/20110331" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:country="http://xbrl.sec.gov/country/2012-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2012-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2012-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.chn-biotics.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition> 001 - Document - DOCUMENT AND ENTITY INFORMATION </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/Consolidatedbalancesheets" id="Consolidatedbalancesheets">
<link:definition> 002 - Statement - CONSOLIDATED BALANCE SHEETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/Consolidatedbalancesheetsparenthetical" id="Consolidatedbalancesheetsparenthetical">
<link:definition> 003 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/ConsolidatedStatementsOfIncomeAndOtherComprehensiveIncome" id="ConsolidatedStatementsOfIncomeAndOtherComprehensiveIncome">
<link:definition> 004 - Statement - CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/Consolidatedstatementsofchangesinstockholdersequity" id="Consolidatedstatementsofchangesinstockholdersequity">
<link:definition> 005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/Consolidatedstatementsofchangesinstockholdersequityparenthetical" id="Consolidatedstatementsofchangesinstockholdersequityparenthetical">
<link:definition> 006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Parenthetical] </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/Consolidatedstatementsofcashflow" id="Consolidatedstatementsofcashflow">
<link:definition> 007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/OrganizationAndDescriptionOfBusiness" id="OrganizationAndDescriptionOfBusiness">
<link:definition> 008 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/SummaryOfPrincipalAccountingPolicies" id="SummaryOfPrincipalAccountingPolicies">
<link:definition> 009 - Disclosure - SUMMARY OF PRINCIPAL ACCOUNTING POLICIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/EarningsPerShare" id="EarningsPerShare">
<link:definition> 010 - Disclosure - EARNINGS PER SHARE </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/RisksUncertaintiesAndConcentrations" id="RisksUncertaintiesAndConcentrations">
<link:definition> 011 - Disclosure - RISKS, UNCERTAINTIES, AND CONCENTRATIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/Inventories" id="Inventories">
<link:definition> 012 - Disclosure - INVENTORIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/LandUseRights" id="LandUseRights">
<link:definition> 013 - Disclosure - LAND USE RIGHTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/PropertyPlantAndEquipment" id="PropertyPlantAndEquipment">
<link:definition> 014 - Disclosure - PROPERTY, PLANT AND EQUIPMENT </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/AmountDueFromtoDirector" id="AmountDueFromtoDirector">
<link:definition> 015 - Disclosure - AMOUNT DUE FROM/TO DIRECTOR </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/ConvertibleNotesPayable" id="ConvertibleNotesPayable">
<link:definition> 016 - Disclosure - CONVERTIBLE NOTES PAYABLE </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/DerivativeLiabilities" id="DerivativeLiabilities">
<link:definition> 017 - Disclosure - DERIVATIVE LIABILITIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/IncomeTaxesPayable" id="IncomeTaxesPayable">
<link:definition> 018 - Disclosure - INCOME TAXES PAYABLE </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/TreasuryStock" id="TreasuryStock">
<link:definition> 019 - Disclosure - TREASURY STOCK </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/CapitalAndStatutoryReserves" id="CapitalAndStatutoryReserves">
<link:definition> 020 - Disclosure - CAPITAL AND STATUTORY RESERVES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/OptionIncentivePlan" id="OptionIncentivePlan">
<link:definition> 021 - Disclosure - OPTION INCENTIVE PLAN </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/ProductReturnConcessions" id="ProductReturnConcessions">
<link:definition> 022 - Disclosure - PRODUCT RETURN CONCESSIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/RetirementCosts" id="RetirementCosts">
<link:definition> 023 - Disclosure - RETIREMENT COSTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 024 - Disclosure - COMMITMENTS AND CONTINGENCIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition> 025 - Disclosure - RELATED PARTY TRANSACTIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/BusinessSegments" id="BusinessSegments">
<link:definition> 026 - Disclosure - BUSINESS SEGMENTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/SelectedQuarterlyFinancialData" id="SelectedQuarterlyFinancialData">
<link:definition> 027 - Disclosure - SELECTED QUARTERLY FINANCIAL DATA </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/PublicOffering" id="PublicOffering">
<link:definition> 028 - Disclosure - PUBLIC OFFERING </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition> 029 - Disclosure - SUBSEQUENT EVENTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.chn-biotics.com/role/CONDENSEDPARENTCOMPANYFINANCIALSTATEMENTS" id="CONDENSEDPARENTCOMPANYFINANCIALSTATEMENTS">
<link:definition> 030 - Schedule - CONDENSED PARENT COMPANY FINANCIAL STATEMENTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="chbt-20110331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="chbt-20110331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="chbt-20110331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="chbt-20110331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://fasb.org/us-gaap/2012-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/invest/2012-01-31" schemaLocation="http://xbrl.sec.gov/invest/2012/invest-2012-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2012-01-31" schemaLocation="http://xbrl.sec.gov/country/2012/country-2012-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2012-01-31" schemaLocation="http://xbrl.sec.gov/currency/2012/currency-2012-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/exch/2012-01-31" schemaLocation="http://xbrl.sec.gov/exch/2012/exch-2012-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2012-01-31" schemaLocation="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://fasb.org/us-types/2012-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2012/elts/us-types-2012-01-31.xsd"/>
<element name="DocumentAndEntityInformationAbstract" id="chbt_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DueToDirectorCurrent" id="chbt_DueToDirectorCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CapitalAndStatutoryReserves" id="chbt_CapitalAndStatutoryReserves" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="BalanceSheetsParentheticalAbstract" id="chbt_BalanceSheetsParentheticalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OtherIncomeAndExchangeGains" id="chbt_OtherIncomeAndExchangeGains" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TotalOperatingExpensesIncludingOtherIncome" id="chbt_TotalOperatingExpensesIncludingOtherIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CapitalAndStatutoryReserveMember" id="chbt_CapitalAndStatutoryReserveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PrepaymentForLongTermCapitalExpenditure" id="chbt_PrepaymentForLongTermCapitalExpenditure" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PaymentToPurchaseTreasuryStock" id="chbt_PaymentToPurchaseTreasuryStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProceedsFromCashAdvanceFromDirector" id="chbt_ProceedsFromCashAdvanceFromDirector" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PaymentsForAdvanceToDirector" id="chbt_PaymentsForAdvanceToDirector" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OrganizationAndDescriptionOfBusinessDisclosureTextBlockTextBlock" id="chbt_OrganizationAndDescriptionOfBusinessDisclosureTextBlockTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountDueFromOrToDirectorDisclosureAbstract" id="chbt_AmountDueFromOrToDirectorDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountDueFromOrToDirectorDisclosureTextBlock" id="chbt_AmountDueFromOrToDirectorDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CapitalAndStatutoryReservesDisclosureAbstract" id="chbt_CapitalAndStatutoryReservesDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CapitalAndStatutoryReservesDisclosureTextBlock" id="chbt_CapitalAndStatutoryReservesDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProductReturnsAbstract" id="chbt_ProductReturnsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProductReturnsTextBlock" id="chbt_ProductReturnsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PublicOfferingAbstract" id="chbt_PublicOfferingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PublicOfferingTextBlock" id="chbt_PublicOfferingTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CapitalizationOfInterestsAmortizationOfDebtDiscountAndAccruedOfInterest" id="chbt_CapitalizationOfInterestsAmortizationOfDebtDiscountAndAccruedOfInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" abstract="false" nillable="true" xbrli:balance="credit"/>
</schema>

↑Top
Filing Submission 0001144204-13-030858   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., May 4, 8:22:08.1am ET